Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study
暂无分享,去创建一个
J. Baron | K. Meguro | B. Desgranges | F. Eustache | B. Landeau | B Desgranges | F Eustache | J-C Baron | B Landeau | K Meguro | C LeMestric | J. Baron | C. LeMestric
[1] R. Albin,et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] J C Mazziotta,et al. Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease. , 1999, Neuroreport.
[3] J. Baron,et al. A PET study of the functional neuroanatomy of writing impairment in Alzheimer's disease. The role of the left supramarginal and left angular gyri. , 1995, Brain : a journal of neurology.
[4] R. Woods,et al. Mapping Histology to Metabolism: Coregistration of Stained Whole-Brain Sections to Premortem PET in Alzheimer's Disease , 1997, NeuroImage.
[5] Arne Brun,et al. PATHOLOGICAL AND POSITRON EMISSION TOMOGRAPHIC CORRELATIONS IN ALZHEIMER'S DISEASE , 1985, The Lancet.
[6] R H Huesman,et al. Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.
[7] M. Baulac,et al. MR determination of hippocampal volume: comparison of three methods. , 1996, AJNR. American journal of neuroradiology.
[8] B. Landeau,et al. Effects of Healthy Aging on the Regional Cerebral Metabolic Rate of Glucose Assessed with Statistical Parametric Mapping , 1996, NeuroImage.
[9] Alan C. Evans,et al. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. , 2000, Cerebral cortex.
[10] A. Smith,et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease , 1994, The Lancet.
[11] D. Amaral,et al. Hippocampal‐neocortical interaction: A hierarchy of associativity , 2000, Hippocampus.
[12] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[13] A. Smith,et al. Use of structural imaging to study the progression of Alzheimer's disease. , 1996, British medical bulletin.
[14] J. Baron,et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. , 1998, Brain : a journal of neurology.
[15] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[16] A. Delacourte,et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.
[17] F Mauguière,et al. Thalamocortical diaschisis: positron emission tomography in humans. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[18] Libero Verard,et al. Fully automatic identification of AC and PC landmarks on brain MRI using scene analysis , 1997, IEEE Transactions on Medical Imaging.
[19] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[20] K. Davis,et al. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. , 1999, Archives of neurology.
[21] K. Ishii,et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease , 1998, Neurology.
[22] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[23] A. Smith,et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography , 1992, The Lancet.
[24] B. Levin,et al. Predominant left hemisphere metabolic dysfunction in dementia. , 1989, Archives of neurology.
[25] H Shibasaki,et al. Cerebral glucose metabolism in unilateral entorhinal cortex-lesioned rats: an animal PET study. , 1999, Neuroreport.
[26] Daniel Bloyet,et al. 3D brain structures extraction using fully automated MRI segmentation , 1995 .
[27] E. Peskind,et al. Alzheimer's disease and related disorders. , 2001, The Medical clinics of North America.
[28] P. Anslow,et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[29] R. Killiany,et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.
[30] J D Watson,et al. Nonparametric Analysis of Statistic Images from Functional Mapping Experiments , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] K. Meguro,et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[32] H. Wiśniewski,et al. Alzheimer's disease and related disorders. , 1986, British medical bulletin.
[33] J V Haxby,et al. High-resolution PET studies in Alzheimer's disease. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[34] R Harrop,et al. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease , 1986, Neurology.
[35] E. Hoffman,et al. TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.
[36] William J. Jagust,et al. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease , 1993, Brain Research.
[37] J. Baron,et al. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. , 1999, Brain : a journal of neurology.